ELEMARB (Small Cap) Share Target 2026, 2027 To 2035
|
Elegant Marbles and Grani Industries Limited |
|||
|
Price: ₹188.95 (1.5%) | ||
| 52 Week Low: ₹132.70 52 Week High: ₹264.90 |
|||
| Market Capital: 59.28 Crore (Small-cap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: ELEMARB Share Price Target For 2026
- 1.1.1: ELEMARB Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: ELEMARB Share Price Target For 2027
- 1.2.1: ELEMARB Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: ELEMARB Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: ELEMARB Financial Performance
- 3.0.1: Is ELEMARB A Good Buy For Long Term?
ELEMARB, a Small Cap company has delivered 24.9% returns in 5-year showing 0.7% quarterly revenue growth with 40.5% profit margin.
To predict the ELEMARB's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
ELEMARB Share Price Target For 2026
The line chart displays the monthly closing prices of ELEMARB with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for ELEMARB shares in 2026, see the table below.
ELEMARB Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 208.59 (+10.39%) | Trend: SMA200 |
| 2026 Target 2 | 196.98 (+4.24%) | Trend: SMA50 |
| 2026 Target 1 | 189.11 (+0.08%) | Trend: EMA9 |
| Current Price | 188.95 | ELEMARB's share price as of 15 Jun 2026 |
| Stop Loss 1 | 175.88 (-6.92%) | Volatility: BB Lower |
| Stop Loss 2 | 169.98 (-10.04%) | 71.80% Weekly Fib Retrace |
| Stop Loss 3 | 161.30 (-14.64%) | Volatility: ATR S1 |
Short-Term Technical Outlook
Current Technical Position: ELEMARB is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹185.67 serves as the nearest technical reference point.
Historical Returns: 3-month: +3.73% | 6-month: -15.44% | 1-year: -25.05%
ELEMARB Share Price Target For 2027
The line chart displays the monthly closing prices of ELEMARB with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for ELEMARB shares in 2027, see the table below.
ELEMARB Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 208.59 (+10.39%) | Trend: SMA200 |
| 2027 Target 2 | 196.98 (+4.24%) | Trend: SMA50 |
| 2027 Target 1 | 189.11 (+0.08%) | Trend: EMA9 |
| Current Price | 188.95 | ELEMARB's share price as of 15 Jun 2026 |
| Stop Loss 1 | 175.88 (-6.92%) | Volatility: BB Lower |
| Stop Loss 2 | 169.98 (-10.04%) | 71.80% Weekly Fib Retrace |
| Stop Loss 3 | 161.30 (-14.64%) | Volatility: ATR S1 |
Long-Term Technical Outlook
52-Week Range Analysis: ELEMARB is currently trading at 42.5% of its 52-week range (₹132.7 - ₹264.9).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -25.05% | 3-year: +12.65% | 5-year: +24.93%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
ELEMARB Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹188.95 | ||
| 2026 | ₹222.25 | +17.623709976184% | ₹225.58 |
| 2027 | ₹252.81 | +13.750281214848% | ₹256.60 |
| 2028 | ₹299.33 | +18.401170839761% | ₹303.82 |
| 2029 | ₹334.27 | +11.672735776568% | ₹339.28 |
| 2030 | ₹435.87 | +30.394591198732% | ₹442.41 |
| 2031 | ₹531.73 | +21.992796017161% | ₹539.71 |
| 2032 | ₹592.03 | +11.340341902845% | ₹600.91 |
| 2033 | ₹677.98 | +14.517845379457% | ₹688.15 |
| 2034 | ₹766.48 | +13.053482403611% | ₹777.98 |
| 2035 | ₹890.99 | +16.24438993842% | ₹904.35 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
ELEMARB Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 100.43 Crore | Market valuation of ELEMARB's shares. |
| Revenue (TTM) | 32.65 Crore | Total revenue generated by ELEMARB over the past twelve months. |
| Net Income (TTM) | +4.05 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 16.71% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 40.54% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+0.67% | Change in revenue compared to the previous quarter. |
| Total Cash | 3.59 Crore | Total amount of liquid funds available to ELEMARB. |
Is ELEMARB A Good Buy For Long Term?
ELEMARB, a small-cap stock with a market capitalization of ₹100.43 crore, presents a mixed picture for long-term investment. While its impressive three-year return (363.11%) and healthy profit margin (12.43%) are positive indicators, recent performance shows a concerning downward trend: -22.53% YTD and -9.74% over the past six months. The company boasts a cash balance of ₹3.59 crore (Q1 2024-25), but its small size and volatile recent performance warrant caution. Therefore, it's currently an average buy, requiring further due diligence before committing to a long-term investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
